Search

everythinglearnresearchcommunity

for

Search:↓

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Alopecia Areata Incognita causes sudden hair loss in young females but usually has a better outcome than other types.

The girl has a genetic hair condition causing thin hair since childhood.

The patient's hair loss is most likely due to diffuse alopecia areata.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Secukinumab can cause hair loss, which may improve after stopping the medication.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The study found specific hair and scalp patterns for different types of hair loss in Koreans, noting racial differences affect diagnosis.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Hair growth dysfunction involves various conditions with limited treatment options.

PRP therapy significantly improved hair growth in a girl with chronic alopecia areata.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Early and accurate diagnosis of posterior scalp hair loss is crucial for effective treatment and better outcomes.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.